减少青少年摄入糖的行为改变技术:系统性审查
C J Moores1,2, A M Taylor3, S Cowap1,3
1Adelaide Dental School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
JDR clinical and translational research
|October 12, 2024
概括
青少年降糖的有效行为改变技术 (BCT) 包括对行为的反,对后果的信息,问题解决和社会比较. 这些策略支持饮食变化,以预防.
科学领域:
- 公共卫生 公共卫生
- 营养科学 营养科学
- 行为科学 行为科学
背景情况:
- 青少年的饮食通常含有大量的糖,增加了脏病的风险.
- 需要有效的策略来支持在这个年龄段减少糖分.
- 预防空需要解决饮食习惯.
研究的目的:
- 系统地审查行为改变技术 (BCT) 的证据,以减少青少年 (10-16岁) 的糖摄入量.
- 确定有效的BCT用于青少年降低糖分.
- 为临床实践和未来研究提供信息.
主要方法:
- 从1990年到2023年对同行评审的证据进行系统审查.
- 在九个主要数据库中搜索相关研究.
- 使用93项BCT分类法 (Michie分类法v1) 的编码干预.
- 评估了偏见的风险,并使用投票计数合成了证据.
主要成果:
- 包含了35项研究,在11个集群中使用了25个个别BCT.
- 降低糖的最有效的BCT是对行为的反 (100%的成功率在强度/中度研究中),关于社会/环境后果的信息 (100%),解决问题 (75%) 和社会比较 (75%).
- 每项研究中均使用3个BCT.
结论:
- 对行为的反,对后果的信息,问题解决和社会比较都得到了强烈的支持,BCT可以降低青少年的糖摄入量.
- 这些发现可以指导临床医生提供有效的饮食建议.
- 结果将为未来的青少年降糖研究方向提供信息.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
167
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
167
Stress Prevention and Stress Management Techniques VI
30
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
30
Diabetes: Management and Pharmacotherapy
246
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
246
Hypoglycemia and Glucagon
224
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
224
Stress Prevention and Stress Management Techniques IV
28
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
28
Glucose Absorption Into the Small Intestine
31.5K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.5K


